MARATTO

article · Annual Research & Review in Biology

Multiple Resistance in Clinical Isolates of Escherichia coli and Plasmid-mediated Quinolone Resistance Genes

Abstract

Quinolone antibiotics have been commonly used to treat cases of multiple antibiotic resistance. Unfortunately, quinolone antibiotics have so much been resisted by infectious bacterial agents. This study aimed to evaluate the susceptibility of some clinical isolates of E. coli to some commonly used quinolone antibiotics and the determination of the plasmid-encoded quinolone resistance genes. Our results showed the plasmid quinolone-resistance genes in the following prevalence: qnr genes: qnr S (71.4 %); qnr B (15.4 %); qnr S and B (12.1 %); aac (6) lb-cr (4 %); Efflux genes: oqxA (7.7 %); oqxB (25.3 %); qepA (12.1 %); oqxA and oqxB (5.5 %). We conclude that there is a high frequency of Plasmid-mediated quinolone resistance genes in Escherichia coli isolates from clinical samples in South-Eastern Nigeria. These could be responsible for the high incidence of quinolone resistance reported in Enugu. There is a need for whole-genome sequencing to map out all resistance genes.

Research topics

  • Bacteriophages and microbial interactions
  • Antibiotic Resistance in Bacteria
  • Probiotics and Fermented Foods

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.9734/arrb/2023/v38i230568

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.